Xu Stella

CIK 00017287414 companiesGRAND CAYMAN, E9

SEC Profile

Transactions

Companies

Filings

CIK

0001728741

Recent Transactions

26 trades

Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2023-05-31+15,000→ 15,000 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2022-06-15+15,000→ 15,000 total
Sale
Design Therapeutics, Inc.$DSGN
Common Stock
2022-03-22$18.63/sh−1,455→ 4,129,950 total
Sale
Design Therapeutics, Inc.$DSGN
Common Stock
2022-03-21$19.01/sh−24,000→ 4,131,405 total
Sale
Design Therapeutics, Inc.$DSGN
Common Stock
2022-03-18$19.04/sh−552,225→ 4,168,605 total
Sale
Design Therapeutics, Inc.$DSGN
Common Stock
2022-03-18$20.34/sh−13,200→ 4,155,405 total
Award
Tempest Therapeutics, Inc.$TPST
Stock Option (Right to Buy)
2021-07-01+6,635→ 6,635 total
Award
Tempest Therapeutics, Inc.$TPST
Stock Option (Right to Buy)
2021-07-01+6,635→ 6,635 total
Award
Tempest Therapeutics, Inc.$TPST
Common Stock
2021-06-25+579,710→ 579,710 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2021-06-24+14,250→ 14,250 total
Conversion
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30+280,991→ 4,720,830 total
Conversion
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30+4,439,839→ 4,439,839 total
Conversion
Design Therapeutics, Inc.$DSGN
Series B Preferred Stock
2021-03-30−458,016→ 0 total
Conversion
Design Therapeutics, Inc.$DSGN
Series A Preferred Stock
2021-03-30−7,236,938→ 0 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30$20.00/sh+10,000→ 4,730,830 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2021-03-25+15,000→ 15,000 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2020-06-11+14,250→ 14,250 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2019-06-13+22,000→ 22,000 total
Conversion
NextCure, Inc.$NXTC
Common Stock
2019-05-13+978,570→ 978,570 total
Purchase
NextCure, Inc.$NXTC
Common Stock
2019-05-13$15.00/sh+125,000→ 1,103,570 total
Conversion
NextCure, Inc.$NXTC
Series B-2 Preferred Stock
2019-05-13−7,861,636→ 0 total
Disposition to Issuer
ARMO BioSciences, Inc.
Stock Option (right to buy)
2018-06-22$10.03/sh−18,000→ 0 total
Disposition from Tender
ARMO BioSciences, Inc.
Common Stock
2018-06-22$50.00/sh−404,900→ 0 total
Award
ARMO BioSciences, Inc.
Stock Option (right to buy)
2018-03-26+18,000→ 18,000 total
Conversion
ARMO BioSciences, Inc.
Series C-1 Convertible Preferred Stock
2018-01-30−404,900→ 0 total
Conversion
ARMO BioSciences, Inc.
Common Stock
2018-01-30+404,900→ 404,900 total

Companies

Recent Filings

Address

C/O QUAN CAPITAL UGLAND HOUSE, PO BOX 309

GRAND CAYMAN, E9, KYI-1104

View on SEC.gov